Twist Bioscience Corp — Director's Dealing 2020

Dec 23, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Twist Bioscience Corp (TWST)
CIK: 0001581280
Period of Report: 2020-12-21

Reporting Person: Daniels Mark (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-12-21	Common Stock	M	6826	$8.82	Acquired	63162	Direct
2020-12-21	Common Stock	M	5625	$10.70	Acquired	68787	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-12-21	Employee Stock Option (right to buy)	$8.82	M	6826	Disposed	2027-09-28	Common Stock (6826)	Direct
2020-12-21	Employee Stock Option (right to buy)	$10.7	M	5625	Disposed	2028-02-01	Common Stock (5625)	Direct

Footnotes

F1: The option is immediately exercisable. 10% of the shares subject to the option vested on September 28, 2017, 15% of the shares subject to the option vested on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.

F2: The option is immediately exercisable. 25% of the shares subject to the option vest on January 1, 2019, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.